Serum levels of CXCL1 are also increased in lung adenocarcinoma patients relative to healthy subjects [126], although another study shows that patients with early-stage NSCLC have lower levels of circulating CXCL1 than healthy subjects [131]. This evidence concerns the gene CXCL1 and non-small cell lung carcinoma.